Publication
Longitudinal gut microbiome dynamics during immunotherapy identify microbial features of clinical benefit in advanced primary liver cancer.
Zhenwei Qian, Jie Han, Beile Lyu, Aizier Ainiwaer, Qiancheng Zhao, Shuai Wang, Jiamin Cheng, Yinyin Li, Ying Sun, Xiannian Zhang, Yinying Lu
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: The gut microbiome has been linked to immune checkpoint inhibitor (ICI) outcomes, but the temporal dynamics of microbial communities during treatment remain poorly characterised. OBJECTIVE: To characterise gut microbiome trajectories during ICI therapy and evaluate whether on-treatment…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Liver Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available